The markets which encompass Asia-Pacific are generally somewhat more mature markets which have seen these products and have been using these technologies. Hence, for spinal fusion, for example, the tendency away from fusion and towards intermediate treatments will be seen in the years to come.
Fusion markets in this region, at over $80 million annually in 2008, are growing at about 6% annually, but through the forecast period (to 2017), that annual growth rate will slip to only 4%.
However, the non-fusion markets in this region are demonstrating annual growth in excess of 21%, illustrating the progressive displacement of traditional fusion procedures by procedures that are less invasive, result in greater mobility and have better long-term prognosis for spine patients.
The MedMarket Diligence report #M510 is described in detail at here. The report may be ordered online for instant download or may be ordered via Google Checkout, below.